TLS
Good from Telstra, guidance range tightened (lifts the low end) and EPS at 9.9c vs 9.6c consensus, a slight beat.

All other guidance components remain unchanged.

The below, from the results deck, is part of the AI related opportunity. Whilst we are seeing a rout in the share prices of many software companies, there should be a very tangible benefit to other companies (like TLS) implementing AI to lower cost, drive efficiency, and hopefully make customers happy. The example below of putting every customer on the new digital stack, and being able to resolve nearly 90% of complaints satisfactorily with AI is a huge cost saving.

Telstra also had an amazing comment that they’d taken their software providers from 400 down to 2 (!) and their software development had improved by 20%.
Cashflows were very good, keeping in mind this was the typically weaker seasonal half.

Subscriber numbers continue to grow.

ARPU continues to rise.

And it continues to buyback a lot of stock, which is driving the earnings per share.

BXB
Looks to be a very large beat by Brambles, relative to consensus. That’s 37.4c compared to consensus closer to 33.5c.

They have narrowed their revenue guidance range (was 3-5%, now 3-4%) but they kept the profit guidance unchanged (8-11% growth) and they’ve upped the free cashflow guidance.
In a way, that’s exactly the investment thesis with BXB. They’ve transformed their business, by taking cost out, losing fewer pallets, driving efficiencies, and lifting their cashflows. All of that appears to be on track. The below graph makes it clear just how extraordinary this looks.

SHL
SHL out with their result. Guidance maintained, and the result was in line with consensus. Note there’s a fair bit of seasonality in their numbers, using the usual 1H vs 2H split, it does look like they are still comfortably heading towards guidance.
It may not leap out at you in the below, but given the size of the 2H weighting, the earnings per share recovery does look quite real, now.

Given ACL and HLS (domestic pathology players) had been quite weak, with negative to slightly positive revenue growth, seeing SHL at ~5% was just quite a bit better.
They also (we’ll have to listen to the earnings call) seemed to suggest that perhaps the US is up for review. That would be a positive, since they don’t seem to quite make the same progress, despite having been there for years. Exiting (selling to Quest or Labcorp) and redeploying to where they are winning would make sense, something we’ve said many times to mgmt over the years.
Cashflows were good.

VNT
Ventia (the old Leighton’s contractors, Transfield, Visionstream and a bunch of other maintenance, minor engineering firms) reported.

Slightly ahead of expectations, across the board, which is a solid outcome.

Full year guidance is for 7-10% on FY25, which at the low end on $257m is ~$274m, which is ahead of consensus for FY26 at $272m. So, using the mid point of guidance suggests we will see consensus EPS upgrades.
Work in hand continues to grow ($22.1bn, +22% YoY), the renewal rate on contracts is ~82%, and 87% of the FY26 revenue is secured, suggesting minimal risk to hitting guidance.
Leverage is quite low at 1.3x, suggesting we will continue to see a favourable dividend/capital management/buyback backdrop.
Margins are pretty robust.

Cashflows are good.

Gearing is quite low. They’ve been doing buybacks, and it looks like there’s more room to continue.

Ventia is a big maintenance firm. But the market is huge, and hence VNT’s market share is not enormous. They’ve executed well, but it is difficult to make VNT a story about growing share. It’s sort of “just a decent, GDP linked business that has a plausible set of tailwinds (maintenance being an essential service, and not one that is set to disappear as AI reshapes everything) that isn’t too expensive”.
WES
The Wesfarmers result was pretty much “fine” on most metrics, really. It’s just that you pay 34x forward.
Kmart has been an amazing success story.

That Anko brand (in Kmart) has proven to be very popular. Plans to take it global remain underway (being sold in Walmart stores, being sold in big European brand name stores, opening their own stores in Asia etc).

Note below, the Target LFL sales number stopped a few years back. But Bunnings continues to trundle along.

It is not easy to grow billion dollar EBIT businesses. The story of WES is still pretty much just Bunnings and Kmart. Everything else is a rounding error. Would it be easier to just spin them out, or are they worth keeping because at some point, you might just get them to scale?

Gearing and cashflows were fine. Returns are excellent. They aren’t a serial issuer of equity or anything. It’s just the valuation. Whilst I am sure the WES retail arm will do better than most domestic retailers if there’s a slowdown brought on by higher interest rates, if you have JBH at 17x, which is a very credible retailer, it’s a bit easier than WES at 34x.
TCL
Transurban was out. Unsurprisingly, it remains the same story. How many cars on the network, how many trucks, is it rising. In their case it is. The West Gate Tunnel opened, which should see more volume in time.

The stock has gone more or less nowhere for a few years. It is simultaneously quite expensive, on most metrics, and, not too bad, if all you go off is the dividend yield. As the banks and resources start to look more expensive, it starts to look quite a bit better as an alternative.
Rates have risen, which has weighed on the stock, even though it does have pretty good inflation passthrough mechanisms.
Still, there was a time there when returns, despite being low, were continually rising (say 2007/8-2014/15) which was very good. But it doesn’t quite seem to be the same.

ZIP
Most ZIPs headline metrics looked good. Total transaction volumes up, earnings up, healthy spread on yield vs funding costs + write offs. They reconfirmed their guidance.
And the strength in the Aussie economy was visible in the below, where arrears rates and net bad debts have trended lower.

What seemingly did the damage is the US net bad debt experience shown below. It does seem to be within what management indicated is the expected range, at least at first glance. Market reaction clearly says otherwise.

A few brokers noted the US total transaction volumes missed expectations, although only by a few percent. For stocks “priced to perfection” that can be enough, although it wasn’t obvious that was the case with ZIP.
Still, you can just make the point that if you think the US is sliding towards recession, then stocks like ZIP face existential risk. It doesn’t seem like that’s the case at all (we were just talking about a US “mid-cycle re-acceleration”!), but still.
MPL
Medibank reported numbers that were “fine”. They pointed to affordability issues, that are causing policyholders to downgrade policies, and they pointed to unsustainable competitive dynamics in the market place, where competitors are chasing volume too aggressively. I think they largely mean NHF (NIB), because they usually have the highest policyholder growth; a rate that’s quite a bit above the industry average.
The operating margin for MPL is the premium revenues minus the claims cost, minus expenses.

The gross margin is just the premiums netting out the claims. On most frames MPL looks good.

Lapse rates are steady. Net policyholder acquisition grew. Not bad really, just below consensus.
Important Information: This document has been prepared by Aequitas Investment Partners Pty Ltd ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of AIP FS Pty Ltd ABN 49 680 982 478 (Australian Financial Services Licensee no. 700016) and is for distribution within Australia to wholesale clients only.
This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.
Past performance is not a reliable indicator of future performance.
General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.
Taxation warning: Aequitas is not authorised to provide tax (financial) advice and is not a registered tax agent. Investors should seek their own tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law. We recommend that you consult a registered tax agent or a tax specialist to confirm your taxation position.